Dividend income keeps flowing whether you are working, sleeping, or on vacation. For investors building a portfolio that pays whether the market is open or closed, high-yield equities offer instant liquidity and zero operational headaches that rental property and private credit cannot match. With the… Read More »Stocks That Pay You While You Sleep
For years, the Drug Enforcement Administration has classified marijuana as a Schedule I substance, alongside many harmful drugs, including heroin, ecstasy, and LSD. Recently, U.S. President Donald Trump has pushed for the rescheduling of marijuana, and last week, his administration eased the rules for licensed… Read More »Marijuana Rescheduling Has Arrived. Don’t Make This Mistake
In the AI era, companies have spent hundreds of billions chasing the next big model. Yet most still wrestle with the same problem: turning flashy technology into daily results that move the needle on revenue, costs, or decisions. Enterprise software budgets keep climbing through 2026,… Read More »Palantir Unlocked The Secret To Massive Growth. Its Stock Is Deeply Mispriced
This AI rally has quickly turned into a data center rally, where you won’t find anything for a sensible price. But that’s only if you ignore this stock. Before we reveal it, it’s a good idea to look at what other “pick and shovel” options… Read More »I’ll Buy This 1 Pick-And-Shovel AI Stock With My Eyes Closed – Here’s Why
SpaceX is preparing for what could be the most consequential stock market event in a generation. In early April 2026, the company confidentially filed paperwork with the SEC for an IPO, with executives reportedly gearing up for roadshows in early June and a summer 2026… Read More »SpaceX IPO: What Everyday Investors Need To Know Before The Biggest Stock Offering In History
Drones that cost $10,000 to $100,000. Missiles that cost millions to shoot them down. Lasers that cost $10 per shot. Memorize those numbers. The conflicts over the next decade and beyond are going to be based on them. To be clear, I don’t want any… Read More »The 3 Numbers You Need To Know About The Economics Of War
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly 1% street expectation. The decision injects over $13 billion into private insurers serving… Read More »5 Stocks That Should Benefit From The 2026 Medicare Advantage Rate Decision
While defense names grabbed the headlines in the immediate aftermath of the start of the Iran war, an unlikely winner emerged from the ensuing shock to the market, with gains of 75% year to date. The broader market has wrestled with supply shocks and inflation… Read More »The Non-Defense Winner Investors Missed In The Iran War Supply Shock
Nike (NYSE:NKE) shares were down 11% in early Wednesday trading, reacting to a quarterly earnings report that beat estimates on the surface but delivered a forward outlook that rattled investors. The selloff pushes NKE stock toward levels not seen in years. The headline numbers looked… Read More »Nike Plummets On Disappointing Forecast: Generational Buy Or Value Trap?
Starbucks’ (NASDAQ: SBUX) stock is down 10% in the last year, while the S&P 500 is 12% higher. Over five years, the stock is down 20% while the S&P is up 62%. Recently, The Wall Street Journal wrote that “Starbucks Has Its Shine Back, CEO… Read More »Starbucks Is Still A Dog